Abstract
Objective Describe and compare the biomechanical severity of head acceleration events (HAEs) associated with diagnosed concussion in elite men’s and women’s rugby league using instrumented mouthguards (iMGs) and evaluate the diagnostic accuracy and screening performance of severity metrics within the current Head Injury Assessment (HIA) process.
Methods A prospective cohort of 398 men and 252 women from Super League teams wore iMGs across 515 matches. Following a matching and data quality screening procedure, 123 HIAs (106 men, 17 women) were matched to HAEs, 52 of which were diagnosed concussions (44 men, 8 women). High-magnitude asymptomatic control HAEs (22,676 men, 3,200 women) were sampled proportionally to the number of HIAs. A range of biomechanical severity metrics were calculated for HAEs. Statistical comparisons between outcomes were made. Receiver operating characteristic (ROC) analysis evaluated diagnostic accuracy (ability to predict diagnosed concussions within the HIA). Precision-recall analysis evaluated screening performance (ability to discriminate observable concussion signs from asymptomatic events).
Results Diagnosed concussions had greater severity than asymptomatic HAEs across all metrics in both sexes. For diagnostic accuracy, area under the ROC curve ranged from 0.61 to 0.72 in men and 0.53 to 0.86 in women. For screening performance, optimal thresholds in several metrics provided theoretical improvements to precision over current thresholds used in rugby, but recall remained <0.20.
Conclusion These findings support integrating iMG-derived severity metrics into a multimodal, clinician-led HIA pathway as objective adjuncts for diagnosis and screening, while reinforcing that they cannot replace clinical judgement or other assessment modalities.
What is already known on this topic Instrumented mouthguards are increasingly used in rugby to quantify head acceleration events and trigger Head Injury Assessment (HIA) alerts, but current screening thresholds based on simple peak kinematics have low sensitivity for identifying HAEs linked with visible concussion signs, and very few iMG-measured concussions, particularly in women, have been reported in current research.
What this study adds This study provides the largest dataset of iMG-measured concussions in any sport, shows that concussive HAEs are more severe than asymptomatic events across multiple biomechanical metrics in both sexes, and identifies several severity metrics with diagnostic accuracy comparable to existing HIA sub-tests and modest theoretical improvements over current screening thresholds.
How this study might affect research, practice or policy These findings support incorporating iMG-derived severity metrics as objective adjuncts within clinician-led HIA pathways, highlight the need for sex-inclusive iMG datasets and multimodal concussion identification, and may inform future refinement of iMG screening thresholds in elite rugby and other contact sports.
Competing Interest Statement
JT, CO, and SS fellowships are part-funded by the Rugby Football League. SW has received research funding from the Rugby Football League. DV is employed in a consultancy capacity by the Rugby Football League. LW is an inventor on three US patents related to instrumented mouthguard technology (U.S. Patent 10,172,555; US Patent 11,589,780; US Patent 12,303,256), has received no royalties, and their work is funded by the Canada Research Chairs Program. MK role is part-funded by the Rugby Football League SJ has a pending patent application related to deep learning‑based brain strain estimation and their work is funded by the National Institutes of Health. RT is employed by World Rugby in a consultancy capacity. BJ is employed in a consultancy capacity by Premiership Rugby and the Rugby Football League and has received research funding from Prevent Biometrics. CO, SW, SR, and CZ report no other competing interests.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval was granted by the Leeds Beckett University Research Ethics Committee (REF: 100411).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Funder Information Declared
